Simplex Trading’s Humacyte HUMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$412K Sell
679,400
-87,500
-11% -$91K ﹤0.01% 3500
2025
Q4
$737K Buy
766,900
+621,200
+426% +$880K ﹤0.01% 2924
2025
Q3
$253K Sell
145,700
-21,500
-13% -$42.1K ﹤0.01% 4661
2025
Q2
$349K Sell
167,200
-60,000
-26% -$115K ﹤0.01% 3898
2025
Q1
$387K Buy
227,200
+83,000
+58% +$312K ﹤0.01% 3671
2024
Q4
$728K Buy
144,200
+113,300
+367% +$561K ﹤0.01% 3168
2024
Q3
$168K Sell
30,900
-37,500
-55% -$247K ﹤0.01% 4697
2024
Q2
$328K Buy
68,400
+53,600
+362% +$279K ﹤0.01% 4127
2024
Q1
$46K Buy
14,800
+12,100
+448% +$40.7K ﹤0.01% 6334
2023
Q4
$7K Sell
2,700
-500
-16% -$1.28K ﹤0.01% 7662
2023
Q3
$9K Sell
3,200
-200
-6% -$662 ﹤0.01% 7251
2023
Q2
$9K Sell
3,400
-17,900
-84% -$64.5K ﹤0.01% 7491
2023
Q1
$65K Buy
21,300
+18,900
+788% +$53.7K ﹤0.01% 5627
2022
Q4
$5K Sell
2,400
-1,700
-41% -$5.16K ﹤0.01% 8058
2022
Q3
$13K Sell
4,100
-20,500
-83% -$78.6K ﹤0.01% 7989
2022
Q2
$78K Buy
24,600
+17,300
+237% +$96.2K ﹤0.01% 5904
2022
Q1
$51K Buy
7,300
+2,800
+62% +$16.3K ﹤0.01% 7099
2021
Q4
$32K Buy
+4,500
New +$44.5K ﹤0.01% 7814

Other funds holding HUMA

Simplex Trading's HUMA Position: Q1 2025 in Review

Simplex Trading sold out of Humacyte (HUMA) in Q1 2025, closing a stake of 96,175 shares — an estimated $361K sold.

Simplex Trading first reported a position in HUMA in Q4 2021 and held it in 11 quarters. The position peaked at $711K in Q3 2024. 168 funds tracked by Wall St. Rank hold HUMA as of Q1 2025.

  • Simplex Trading reported no remaining Humacyte position as of Q1 2025 after selling out during the quarter.
  • Simplex Trading sold 96,175 Humacyte shares in Q1 2025, an estimated $361K.
  • Simplex Trading first reported a position in Humacyte in Q4 2021 and held it in 11 quarters.
  • Simplex Trading's Humacyte position peaked at $711K in Q3 2024.
  • 168 funds tracked by Wall St. Rank held Humacyte as of Q1 2025.

Based on Simplex Trading's 13F filing for Q1 2025, filed 12 May 2025.